[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
United Therapeutics (UTHR) reported insider transactions by its Chairperson & CEO under a Rule 10b5-1 plan. On 10/27/2025 and 10/28/2025, the insider exercised 4,000 stock options each day at an exercise price of $120.26 per share and sold the resulting shares in open-market trades.
Sales on 10/27 were 1,000 shares at $411.9545, 1,814 at $414.4191, and 1,186 at $420.2887. Sales on 10/28 were 1,991 at $413.5798, 509 at $415.02, and 1,500 at $417.915. Following these transactions, direct holdings were 130 shares. Indirect holdings include 166 by spouse, 324,518 and 257,117 by family trusts, and 45,596 and 15,962 via spouse-related trusts.
The filing states the 10b5-1 plan was entered on May 2, 2025 and will continue until the earlier of exhaustion of a tranche of 294,000 options expiring March 15, 2026 or December 31, 2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 8,000 shares ($3,323,728)
Net Sell
15 txns
Insider
ROTHBLATT MARTINE A
Role
Chairperson & CEO
Sold
8,000 shs ($3.32M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option | 4,000 | $0.00 | -- |
| Exercise | Common Stock | 4,000 | $120.26 | $481K |
| Sale | Common Stock | 1,991 | $413.5798 | $823K |
| Sale | Common Stock | 509 | $415.02 | $211K |
| Sale | Common Stock | 1,500 | $417.915 | $627K |
| Exercise | Stock Option | 4,000 | $0.00 | -- |
| Exercise | Common Stock | 4,000 | $120.26 | $481K |
| Sale | Common Stock | 1,000 | $411.9545 | $412K |
| Sale | Common Stock | 1,814 | $414.4191 | $752K |
| Sale | Common Stock | 1,186 | $420.2887 | $498K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option — 146,000 shares (Direct);
Common Stock — 4,130 shares (Direct);
Common Stock — 166 shares (Indirect, by Spouse)
Footnotes (1)
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025. This transaction was executed in multiple trades at prices ranging from $411.92 to $412.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $414.02 to $414.75. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $420.04 to $420.63. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $413.15 to $413.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $417.705 to $418.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
